Hyperleukocytosis: A report of five cases and review of the literature
- Authors:
- Junmei Gong
- Bijia Wu
- Tianjian Guo
- Silang Zhou
- Benfu He
- Xinzhao Peng
View Affiliations
Affiliations: Department of Haematology, Chinese People's Liberation Army No. 421 Hospital, Guangzhou, Guangdong 510310, P.R. China
- Published online on: July 8, 2014 https://doi.org/10.3892/ol.2014.2326
-
Pages:
1825-1827
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Hyperleukocytosis (white blood cell count, >100x109/l), an uncommon presentation of leukemia, is associated with an increased risk of early mortality. It may present with a variety of symptoms secondary to leukostasis, a syndrome caused by the sludging of circulating leukemic blasts in the microvasculature. Adequate measures for managing this medical emergency include hydration, cytoreduction, prevention of tumor lysis and, rarely, leukapheresis in cases complicated by leukostasis and hyperviscosity syndrome. The present study reports a case series of five patients with hyperleukocytic leukemia. In addition, a review of the literature with regard to the incidence, pathophysiology, clinical manifestations and management of this laboratory abnormality is included. This study demonstrated that the central nervous system and lungs are the most common sites for leukostasis, and that emergency cases require aggressive treatment.
View References
|
1
|
Ruggiero A, Attinà G, Piastra M, et al:
Severe hyperleukocytosis and multifocal intracranial haemorrhage:
not always a fatal outcome. Int J Hematol. 90:87–90. 2009.
|
|
2
|
Oliveira LC, Romano LG, Prado-Junior BP,
et al: Outcome of acute myeloid leukemia patients with
hyperleukocytosis in Brazil. Med Oncol. 27:1254–1259. 2010.
|
|
3
|
Piro E, Carillio G, Levato L, Kropp M and
Molica S: Reversal of leukostasis-related pulmonary distress
syndrome after leukapheresis and low-dose chemotherapy in acute
myeloid leukemia. J Clin Oncol. 29:e725–e726. 2011.
|
|
4
|
Cui JW, Wang J, He K, et al: Proteomic
analysis of human acute leukemia cells: insight into their
classification. Clin Cancer Res. 10:6887–6896. 2004.
|
|
5
|
Shiber JR and Fines RE: Cerebral
hemorrhage due to hyperleukocytosis. J Emerg Med. 40:674–677.
2011.
|
|
6
|
Bruserud Ø, Liseth K, Stamnesfet S, et al:
Hyperleukocytosis and leukocytapheresis in acute leukaemias:
experience from a single centre and review of the literature of
leukocytapheresis in acute myeloid leukaemia. 23:397–406. 2013.
|
|
7
|
Porcu P, Cripe LD, Ng EW, et al:
Hyperleukocytic leukemias and leukostasis: a review of
pathophysiology, clinical presentation and management. Leuk
Lymphoma. 39:1–18. 2000.
|
|
8
|
Dixit A, Chatterjee T, Mishra P, et al:
Disseminated intravascular coagulation in acute leukemia at
presentation and during induction therapy. Clin Appl Thromb Hemost.
13:292–298. 2007.
|
|
9
|
Inaba H, Fan Y, Pounds S, et al: Clinical
and biologic features and treatment outcome of children with newly
diagnosed acute myeloid leukemia and hyperleukocytosis. Cancer.
113:522–529. 2008.
|
|
10
|
Fischer MJ and Rheingold SR: Oncologic
emergencies. Principles and Practices of Pediatric Oncology. Pizzo
PA and Poplack DG: 6th edition. Lippencott Williams and Wilkins;
Philadelphia: pp. 1125–1151. 2011
|
|
11
|
Majhail NS and Lichtin AE: Acute leukemia
with a very high leukocyte count: confronting a medical emergency.
Cleve Clin J Med. 71:633–637. 2004.
|
|
12
|
Jain R, Bansal D and Marwaha RK:
Hyperleukocytosis: emergency anagement. Indian J Pediatr.
80:144–148. 2013.
|
|
13
|
Ganzel C, Becker J, Mintz PD, Lazarus HM
and Rowe JM: Hyperleukocytosis, leukostasis and leukapheresis:
practice management. Blood Rev. 26:117–122. 2012.
|
